122 related articles for article (PubMed ID: 32746474)
1. Prognostic Factors and Survival in Resected T4 Non-small Cell Lung Cancer: Is There Any Difference in the T4 Subgroups?
Aksoy Y; Citak N; Obuz C; Acikmese B; Pekcolaklar A; Metin M; Sayar A
Zentralbl Chir; 2021 Jun; 146(3):335-343. PubMed ID: 32746474
[TBL] [Abstract][Full Text] [Related]
2. The prognostic impact of the mediastinal fat tissue invasion in patients with non-small cell lung cancer.
Çitak N; Aksoy Y; İşgörücü Ö; Obuz C; Açıkmeşe B; Büyükkale S; Fener NA; Metin M; Sayar A
Gen Thorac Cardiovasc Surg; 2021 Jan; 69(1):76-83. PubMed ID: 32676942
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors related to postoperative survival in the newly classified clinical T4 lung cancer.
Yamanashi K; Menju T; Hamaji M; Tanaka S; Yutaka Y; Yamada Y; Nakajima D; Ohsumi A; Aoyama A; Sato T; Chen-Yoshikawa TF; Sonobe M; Date H
Eur J Cardiothorac Surg; 2020 Apr; 57(4):754-761. PubMed ID: 31633154
[TBL] [Abstract][Full Text] [Related]
4. Survival and prognostic factors of surgically resected T4 non-small cell lung cancer.
Osaki T; Sugio K; Hanagiri T; Takenoyama M; Yamashita T; Sugaya M; Yasuda M; Yasumoto K
Ann Thorac Surg; 2003 Jun; 75(6):1745-51; discussion 1751. PubMed ID: 12822610
[TBL] [Abstract][Full Text] [Related]
5. Survival and risk factors of surgically treated mediastinal invasion T4 non-small cell lung cancer.
Yang HX; Hou X; Lin P; Rong TH; Yang H; Fu JH
Ann Thorac Surg; 2009 Aug; 88(2):372-8. PubMed ID: 19632375
[TBL] [Abstract][Full Text] [Related]
6. Results of T4 surgical cases in the Japanese Lung Cancer Registry Study: should mediastinal fat tissue invasion really be included in the T4 category?
Watanabe S; Asamura H; Miyaoka E; Okumura M; Yoshino I; Fujii Y; Nakanishi Y; Eguchi K; Mori M; Sawabata N; Yokoi K;
J Thorac Oncol; 2013 Jun; 8(6):759-65. PubMed ID: 23608818
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the T descriptors and other prognosis factors in pathologic stage I non-small cell lung cancer in China.
Li Z; Yu Y; Lu J; Luo Q; Wu C; Liao M; Zheng Y; Ai X; Gu L; Lu S
J Thorac Oncol; 2009 Jun; 4(6):702-9. PubMed ID: 19404215
[TBL] [Abstract][Full Text] [Related]
8. [Survival and prognostic factors in resected satellite-nodule T4 non-small cell lung cancer].
Ma K; Wang TY; He BL; Chang D; Hu XD; Yin ZY; Jiang H; Cui Y; Gao Z; Gong M
Zhonghua Wai Ke Za Zhi; 2009 Jan; 47(2):120-2. PubMed ID: 19563007
[TBL] [Abstract][Full Text] [Related]
9. Significant prognostic factors for completely resected pN2 non-small cell lung cancer without neoadjuvant therapy.
Uehara H; Nakao M; Mun M; Nakagawa K; Nishio M; Ishikawa Y; Okumura S
Ann Thorac Cardiovasc Surg; 2015; 21(4):345-53. PubMed ID: 25740454
[TBL] [Abstract][Full Text] [Related]
10. [Surgical results of T4 lung cancer invading left atrium and great vessels].
Mu JW; Lü F; Wang YG; Li J; Mao YS; Fang DK; Liu XY; Meng PJ; Yang L; Cheng GY; Sun KL; Zhang DC; Zhang RG; Zhang DW; Huang GJ; He J
Zhonghua Yi Xue Za Zhi; 2008 Feb; 88(6):383-6. PubMed ID: 18581890
[TBL] [Abstract][Full Text] [Related]
11. Surgical multimodality treatment for baseline resectable stage IIIA-N2 non-small cell lung cancer. Degree of mediastinal lymph node involvement and impact on survival.
Decaluwé H; De Leyn P; Vansteenkiste J; Dooms C; Van Raemdonck D; Nafteux P; Coosemans W; Lerut T
Eur J Cardiothorac Surg; 2009 Sep; 36(3):433-9. PubMed ID: 19502079
[TBL] [Abstract][Full Text] [Related]
12. Risk Factors for Occult Lymph Node Metastasis in Peripheral Non-Small Cell Lung Cancer with Invasive Component Size 3 cm or Less.
Moon Y; Choi SY; Park JK; Lee KY
World J Surg; 2020 May; 44(5):1658-1665. PubMed ID: 31912252
[TBL] [Abstract][Full Text] [Related]
13. Prognostic impact of lymphovascular invasion compared with that of visceral pleural invasion in patients with pN0 non-small-cell lung cancer and a tumor diameter of 2 cm or smaller.
Tao H; Hayashi T; Sano F; Takahagi A; Tanaka T; Matsuda E; Okabe K
J Surg Res; 2013 Nov; 185(1):250-4. PubMed ID: 23830361
[TBL] [Abstract][Full Text] [Related]
14. False-positivity of mediastinal lymph nodes has negative effect on survival in potentially resectable non-small cell lung cancer.
Iskender I; Kadioglu SZ; Cosgun T; Kapicibasi HO; Sagiroglu G; Kosar A; Kir A
Eur J Cardiothorac Surg; 2012 Apr; 41(4):874-9. PubMed ID: 22423060
[TBL] [Abstract][Full Text] [Related]
15. Results of surgical treatment of T4 non-small cell lung cancer.
Pitz CC; Brutel de la Rivière A; van Swieten HA; Westermann CJ; Lammers JW; van den Bosch JM
Eur J Cardiothorac Surg; 2003 Dec; 24(6):1013-8. PubMed ID: 14643822
[TBL] [Abstract][Full Text] [Related]
16. Incidence of occult pN2 disease following resection and mediastinal lymph node dissection in clinical stage I lung cancer patients.
Bille A; Woo KM; Ahmad U; Rizk NP; Jones DR
Eur J Cardiothorac Surg; 2017 Apr; 51(4):674-679. PubMed ID: 28200091
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors and survival in patients undergoing surgery for T4 nonsmall cell lung carcinoma.
Citak N; Büyükkale S; Sayar A; Metin M; Pekçolaklar A; Gürses A
Acta Chir Belg; 2014; 114(1):17-24. PubMed ID: 24720133
[TBL] [Abstract][Full Text] [Related]
18. Extent of lung resection in non-small lung cancer with interlobar lymph node involvement.
Gunluoglu MZ; Demir A; Turna A; Sansar D; Melek H; Dincer SI; Gurses A
Ann Thorac Cardiovasc Surg; 2011; 17(3):229-35. PubMed ID: 21697782
[TBL] [Abstract][Full Text] [Related]
19. Treatment of clinical T4 stage superior sulcus non-small cell lung cancer: a propensity-matched analysis of the surveillance, epidemiology, and end results database.
Wen J; Liu D; Chen D; Chen J; Xu X; Chen C; Zhang F; Duan S; Zhu R; Fan M; Chen Y
Biosci Rep; 2019 Feb; 39(2):. PubMed ID: 30647107
[No Abstract] [Full Text] [Related]
20. Staging and resection of lung cancer with minimal invasion of the adjacent lobe.
Demir A; Gunluoglu MZ; Sansar D; Melek H; Dincer SI
Eur J Cardiothorac Surg; 2007 Dec; 32(6):855-8. PubMed ID: 17936002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
